Pharma Journalist -

Lyophilization Services of New England (LSNE) announced a strategic plan to expand its Quality Control (QC) laboratory in Bedford, NH, and provide new employment opportunities for its…
Read More...

Inovio Pharmaceuticals and CEPI – the Coalition for Epidemic Preparedness Innovations – announced a partnership under which Inovio will develop vaccine candidates against Lassa fever…
Read More...

Zealand Pharma reports that it has engaged in a collaboration with Roche Diabetes Care for the Phase 3 trials with dasiglucagon for treatment of congenital hyperinsulinism (CHI).…
Read More...

Promethera Biosciences SA announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated…
Read More...

Pfizer has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX's network of healthcare organizations to support…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor DISPERZ (everolimus tablets for oral suspension), for the adjunctive treatment of adult and…
Read More...

Charles River Laboratories International, Inc. and PathoQuest announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS) services to the…
Read More...

Novartis announced that it has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical stage gene therapy company for USD 218 per…
Read More...

Protalex, Inc. announced that the Company has enrolled the first of three patients in cohort four of its U.S./U.K. Phase 1/2 trial evaluating PRTX-100 for the treatment of adults with…
Read More...

Allele Biotechnology & Pharmaceuticals Inc. has received a Tissue Bank License from the California Department of Public Health, making it the world’s first establishment to collect…
Read More...